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Process intensification leveraging perfusion offers tremendous potential for yield improvement over fed-batch 
processes for the production of monoclonal antibodies.  In the context of continuous processing, the goal is to 
achieve highly intensified perfusion processes that allow substantial footprint reduction and enable flexible 
adaptation in new facilities.  However developing a perfusion process and medium without prior technology 
requires leveraging the existing fed-batch platform knowledge.  Evolving a medium for perfusion relies on 
designing suitable mixtures of basal and feed media that serve as adequate starting points for development.  
Focus on optimization of the medium to decrease byproduct waste, reduce unnecessary cell growth and 
enhance specific productivity is critical.  Doing so would allow a more robust and controlled process, and allow 
steady-state to be more attainable which will aid in maintaining consistent product quality for continuous 
processing.  Moreover, reducing medium utilization hence the ability to operate under lower cell specific 
perfusion rate was important in order to have a more economical and nimble process.  In order to overcome the 
conventional perfusion medium bottlenecks of equipment capacity, liquid handling, transfer and storage, a 
different strategy to managing large bulk volume had to be undertaken in order to make fit for an existing small 
pilot plant.  The approach to establishing a first generation perfusion process starting from a fed-batch platform 
will be shared.  Examples demonstrating continuous perfusion and volumetric productivity of > 1 g/L-day under 
low CSPR will be discussed.                
 
